Digeranyl Bisphosphonate

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameDigeranyl Bisphosphonate
Drug Alias Nameterpenoid-modified bisphosphonates (Terpenoid Therapeutics)OX-14DGBP
ClassificationSmall molecules
Mechanisms of ActionGeranylgeranyl pyrophosphate synthase inhibitors
TargetsGeranylgeranyl pyrophosphate synthase
Therapy Area/IndicationsPulmonary FibrosisOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTerpenoid Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTerpenoid Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary FibrosisOsteoporosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A